Gheorghita Isvoranu

Dr. Gheorghita Isvoranu

Victor Babes National Institute of Pathology, Bucharest Romania
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
GIGheorghita Isvoranu
Gheorghita Isvoranu
MSMihaela Surcel
Mihaela Surcel
AMAdriana Narcisa Munteanu
Adriana Narcisa Munteanu
OBOvidiu Gabriel Bratu
Ovidiu Gabriel Bratu
FIFlorentina Ionita‑Radu
Florentina Ionita‑Radu
MCMarioara Chiritoiu‑Butnaru
Marioara Chiritoiu‑Butnaru
The immune system is dysfunctional in cancer, and therapeutic approaches designated to restore immunity and increase long‑term overall survival are desirable. The role of immunotherapy is to trigger the immune system to recognize and destroy tumor cells. Interleukin‑15 (IL‑15) is a member of the common gamma‑chain (γc) cytokines that promote the differentiation and expansion of T cells, B cells and natural killer (NK) cells, leading to enhanced antitumor responses. This suggests that IL‑15 is a promising candidate for anticancer therapy. Renewed interest in cancer immunotherapy has led to an increased number of preclinical studies and clinical trials that have investigated the reliability and potency of IL‑15‑based agents, not only as single therapy, but also in combination with others. This review provides a description of these studies which show the advantages and disadvantages of IL‑15 as an immunotherapeutic agent. We present here the role of IL‑15 and pharmacologically improved IL‑15 superagonists as a single treatment or in combination with other therapeutic agents.

4 April 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GIGheorghita Isvoranu
Gheorghita Isvoranu
MCMarioara Chiritoiu-Butnaru
Marioara Chiritoiu-Butnaru
Interleukin-21 (IL-21) is an immunostimulatory cytokine which belongs to the common gamma-chain family of cytokines. It plays an import role in the development, differentiation, proliferation, and activation of immune cells, in particular T and natural killer (NK) cells. Since its discovery in 2000, IL-21 has been shown to regulate both adaptive and immune responses associates with key role in antiviral and antitumor responses. Recent advances indicate IL-21 as a promising target for cancer treatment and encouraging results were obtained in preclinical studies which investigated the potency of IL-21 alone or in combination with other therapies, including monoclonal antibodies, checkpoint inhibitory molecules, oncolytic virotherapy, and adoptive cell transfer. Furthermore, IL-21 showed antitumor effects in the treatment of patients with advanced cancer, with minimal side effects in several clinical trials. In the present review, we will outline the recent progress in IL-21 research, highlighting the potential of IL-21 based therapy as single agent or in combination with other drugs to enhance cancer treatment efficiency.

1 September 2020 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
RMRadu Dragos Marcu
Radu Dragos Marcu
DMDan Liviu Dorel Mischianu
Dan Liviu Dorel Mischianu
LILucian Iorga
Lucian Iorga
CDCamelia Cristina Diaconu
Camelia Cristina Diaconu
MSMihaela Surcel
Mihaela Surcel
OBOvidiu Gabriel Bratu
Ovidiu Gabriel Bratu
Pelvic organ prolapse is a frequent health problem in women, encountered worldwide, its physiopathology being still incompletely understood. The integrity of the pelvic-supportive structures is a key element that prevents the prolapse of the pelvic organs. Numerous researchers have underlined the role of connective tissue molecular changes in the pathogenesis of pelvic organ prolapse and have raised the attention upon oxidative stress as an important element involved in its appearance. The advancements made over the years in terms of molecular biology have allowed researchers to investigate how the constituent elements of the pelvic-supportive structures react in conditions of oxidative stress. The purpose of this paper is to underline the importance of oxidative stress in the pathogenesis of pelvic organ prolapse, as well as to highlight the main oxidative stress molecular changes that appear at the level of the pelvic-supportive structures. Sustained mechanical stress is proven to be a key factor in the appearance of pelvic organ prolapse, correlating with increased levels of free radicals production and mitochondrial-induced fibroblasts apoptosis, the rate of cellular apoptosis depending on the intensity of the mechanical stress, and the period of time the mechanical stress is applied. Oxidative stress hinders normal cellular signaling pathways, as well as different important cellular components like proteins, lipids, and cellular DNA, therefore significantly interfering with the process of collagen and elastin synthesis.

19 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
GIGheorghita Isvoranu
Gheorghita Isvoranu
EMEmilia Manole
Emilia Manole
Monica NeaguMonica Neagu
Monica Neagu
The present review discusses recent data regarding rodent models of spinal cord and peripheral nerve injuries in terms of gait analysis using the CatWalk system (CW), an automated and exceptionally reliable system for assessing gait abnormalities and motor coordination. CW is a good tool for both studying improvements in the walking of animals after suffering a peripheral nerve and spinal cord lesion and to select the best therapies and procedures after tissue destruction, given that it provides objective and quantifiable data. Most studies using CW for gait analysis that were published in recent years focus on injuries inflicted in the peripheral nerve, spinal cord, and brain. CW has been used in the assessment of rodent motor function through high-resolution videos, whereby specialized software was used to measure several aspects of the animal’s gait, and the main characteristics of the automated system are presented here. CW was developed to assess footfall and gait changes, and it can calculate many parameters based on footprints and time. However, given the multitude of parameters, it is necessary to evaluate which are the most important under the employed experimental circumstances. By selecting appropriate animal models and evaluating peripheral nerve and spinal cord lesion regeneration using standardized methods, suggestions for new therapies can be provided, which represents the translation of this methodology into clinical application.

Verified
Journal Article
Open access
PDF file
MSMihaela Surcel
Mihaela Surcel
MNMunteanu Adriana Narcisa
Munteanu Adriana Narcisa
GIGheorghita Isvoranu
Gheorghita Isvoranu
AIAlef Ibram
Alef Ibram
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
Monica NeaguMonica Neagu
Monica Neagu
Psoriasis has a multifactorial pathogenesis and recently it was shown that alterations in the skin and intestinal microbiome are involved in the pathogenesis of psoriasis. Therefore, microbiome restoration becomes a promising preventive/therapy strategy in psoriasis. In our pre-clinical study design using a mice model of induced psoriatic dermatitis (Ps) we have tested the proof-of-concept that IgY raised against pathological human bacteria resistant to antibiotics can alleviate psoriatic lesions and restore deregulated immune cell parameters. Besides clinical evaluation of the mice and histology of the developed psoriatic lesions, cellular immune parameters were monitored. Immune cells populations/subpopulations from peripheral blood and spleen cell suspensions that follow the clinical improvement were assessed using flow cytometry. We have quantified T lymphocytes (CD3ε+) with T-helper (CD4+CD8−) and T-suppressor/cytotoxic (CD8a+CD4−) subsets, B lymphocytes (CD3ε−CD19+) and NK cells (CD3ε−NK1.1+). Improved clinical evolution of the induced Ps along with the restoration of immune cells parameters were obtained when orally IgY was administered. We pin-point that IgY specific compound can be used as a possible pre-biotic-like alternative adjuvant in psoriasis.

Verified
Journal Article
Open access
PDF file
MSMihaela Surcel
Mihaela Surcel
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
AMAdriana Narcisa Munteanu
Adriana Narcisa Munteanu
Diana Antonia CosteaDiana Antonia Costea
Diana Antonia Costea
GIGheorghita Isvoranu
Gheorghita Isvoranu
Monica NeaguMonica Neagu
Monica Neagu
Background: Despite all the available treatments, psoriasis remains incurable; therefore, finding personalized therapies is a continuous challenge. Psoriasis is linked to a gut microbiota imbalance, highlighting the importance of the gut–skin axis and its inflammatory mediators. Restoring this imbalance can open new perspectives in psoriasis therapy. We investigated the effect of purified IgY raised against pathological human bacteria antibiotic-resistant in induced murine psoriatic dermatitis (PSO). Methods: To evaluate the immune portrayal in an imiquimod experimental model, before and after IgY treatment, xMAP array and flow cytometry were used. Results: There were significant changes in IL-1α,β, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17a, IFN-γ, TNF-α, IP-10/CXCL10, MCP-1/CCL2, MIP-1α/CCL3, MIP-1β/CCL4, MIG/CXCL9, and KC/CXCL1 serum levels. T (CD3ε+), B (CD19+) and NK (NK1.1+) cells were also quantified. In our model, TNF-α, IL-6, and IL-1β cytokines and CXCL1 chemokine have extremely high circulatory levels in the PSO group. Upon experimental therapy, the cytokine serum values were not different between IgY-treated groups and spontaneously remitted PSO. Conclusions: Using the murine model of psoriatic dermatitis, we show that the orally purified IgY treatment can lead to an improvement in skin lesion healing along with the normalization of cellular and humoral immune parameters.